List of insiders holdings for INFINITY PHARMACEUTICALS INC C:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2022-02-14 14:01:09 | 6,353,645 0 | 6,353,645 | Form 13G |
| SCHNELL DAVID 10% Owner | 2006-09-22 19:01:06 | 26,938 2,102,398 | 2,129,336 | Form 3 |
| BARKAS ALEXANDER E 10% Owner | 2006-09-22 19:00:23 | 26,938 2,102,398 | 2,129,336 | Form 3 |
| Perkins Adelene Q Director | 2023-09-12 18:20:24 | 1,175,291 16,447 | 1,191,738 | Form 4 |
| PIGLIUCCI RICCARDO Former Chairman & CEO | 2006-02-24 18:06:44 | 653,463 0 | 653,463 | Form 4 |
| Kutok Jeffery Chief Scientific Officer | 2020-01-13 17:01:04 | 527,376 10,744 | 538,120 | Form 4 |
| BLOCH LAWRENCE E President | 2022-01-12 17:00:50 | 335,000 0 | 335,000 | Form 4 |
| ADAMS JULIAN President of R&D | 2016-11-02 16:56:06 | 59,150 262,945 | 322,095 | Form 4 |
| EVNIN ANTHONY B Director | 2022-06-16 21:29:24 | 260,403 0 | 260,403 | Form 4 |
| Tasker Seth A Chief Business Officer | 2022-01-12 17:00:48 | 225,000 0 | 225,000 | Form 4 |
| Bertrand William C JR General Counsel | 2015-10-21 16:18:29 | 200,000 0 | 200,000 | Form 4 |
| Lam Winston K.C. General Counsel | 2015-04-15 18:04:49 | 200,000 0 | 200,000 | Form 4 |
| Berkowitz Jeffrey Director | 2019-06-14 16:05:22 | 115,238 0 | 115,238 | Form 4 |
| LANDER ERIC S Director | 2016-06-21 17:53:10 | 100,319 11,051 | 111,370 | Form 4 |
| KANGO SUJAY Director | 2022-03-31 19:08:25 | 90,000 0 | 90,000 | Form 4 |
| Ilaria Robert Jr. Chief Medical Officer | 2022-01-12 17:00:42 | 87,472 0 | 87,472 | Form 4 |
| KUSSMAN CRAIG Chief Financial Officer | 2004-07-13 19:25:57 | 85,000 0 | 85,000 | Form 4 |
| Roth David Chief Medical Officer | 2015-01-16 16:15:35 | 85,000 0 | 85,000 | Form 4 |
| SCHWARTZ BRIAN Director | 2022-06-16 20:32:29 | 75,919 0 | 75,919 | Form 4 |
| HOEHN DIETER Director | 2003-05-16 13:34:23 | 70,000 0 | 70,000 | Form 4 |
| SMITH IAN F Director | 2018-06-14 08:34:48 | 69,845 0 | 69,845 | Form 4 |
| SELBY NORMAN C Director | 2022-06-16 20:37:31 | 55,000 0 | 55,000 | Form 4 |
| LILLIG JOHN Chief Technology Officer | 2004-07-13 19:26:22 | 46,000 0 | 46,000 | Form 4 |
| BEIER DAVID W Director | 2022-06-16 20:52:18 | 45,000 0 | 45,000 | Form 4 |
| Agresta Samuel Director | 2022-06-16 20:42:58 | 45,000 0 | 45,000 | Form 4 |
| GAYNOR RICHARD Director | 2022-06-16 20:43:00 | 45,000 0 | 45,000 | Form 4 |
| REGENASS URS Vice President | 2004-07-13 19:27:17 | 44,000 0 | 44,000 | Form 4 |
| Lindblom Christopher M Principal Accounting Officer | 2016-05-04 16:22:45 | 40,000 0 | 40,000 | Form 4 |
| Baselga Jose Director | 2017-01-09 16:47:04 | 40,000 0 | 40,000 | Form 4 |
| Quirk Gerald E See Remarks | 2012-01-09 12:55:33 | 40,000 0 | 40,000 | Form 4 |
| NEALE RICHARD Vice President | 2006-08-16 13:26:05 | 39,635 0 | 39,635 | Form 4 |
| Peluso Stephane Chief Scientific Officer | 2022-08-04 18:26:16 | 37,052 0 | 37,052 | Form 4 |
| Burke Thomas Joseph Assistant Treasurer | 2006-09-13 19:58:51 | 33,704 0 | 33,704 | Form 4 |
| Harvey Daniel Vice President | 2005-08-31 15:13:46 | 31,628 0 | 31,628 | Form 4 |
| VENUTI MICHAEL C Director | 2020-06-18 08:34:18 | 30,000 0 | 30,000 | Form 4 |
| Kauffman Michael Director | 2019-06-14 16:05:27 | 30,000 0 | 30,000 | Form 4 |
| LIVINGSTON DOUGLAS A SVP Chemistry | 2004-07-13 19:26:46 | 25,000 0 | 25,000 | Form 4 |
| Tucker Winselow S. Jr. Vice President, Marketing | 2013-01-08 08:24:47 | 22,410 0 | 22,410 | Form 4 |
| Santabarbara Pedro Chief Medical Officer | 2014-01-14 18:01:05 | 16,600 0 | 16,600 | Form 4 |
| Tong Jeffrey K VP, Cor. & Product Development | 2010-01-07 16:16:44 | 15,440 0 | 15,440 | Form 4 |
| Lynch Thomas J. Jr. Director | 2013-06-13 16:38:31 | 15,000 0 | 15,000 | Form 4 |
| Fyfe Gwen A. Director | 2015-06-16 16:33:56 | 15,000 0 | 15,000 | Form 4 |
| WALKER JOHN PETER Director | 2005-05-13 13:42:36 | 15,000 0 | 15,000 | Form 4 |
| Babler Martin Director | 2013-06-13 16:42:54 | 15,000 0 | 15,000 | Form 4 |
| Hamermesh Joshua VP, Business & Corporate Dev | 2013-01-08 08:30:08 | 14,940 0 | 14,940 | Form 4 |
| LEWIS ALAN Director | 2006-05-12 14:15:04 | 10,000 0 | 10,000 | Form 4 |
| DOLLERY COLIN Director | 2006-05-12 14:14:42 | 10,000 0 | 10,000 | Form 4 |
| Palombella Vito J. Chief Scientific Officer | 2015-06-16 16:15:20 | 868 6,741 | 7,609 | Form 4 |
| LEVINE ARNOLD J Director | 2011-05-19 21:53:42 | 6,000 0 | 6,000 | Form 4 |
| TANANBAUM JAMES B Director | 2011-05-19 21:52:08 | 6,000 0 | 6,000 | Form 4 |
| Lee Patrick Pak-Tin Director | 2012-05-18 15:02:33 | 6,000 0 | 6,000 | Form 4 |
| Moss Franklin Director | 2010-05-27 16:05:34 | 5,625 0 | 5,625 | Form 4 |
| HIXSON HARRY F JR Director | 2009-06-19 13:45:33 | 5,625 0 | 5,625 | Form 4 |
| Holtzman Steven H Director | 2012-06-04 17:23:26 | 0 3,945 | 3,945 | Form 4 |
| ROSENMAN HERM Director | 2007-09-14 15:53:39 | 3,750 0 | 3,750 | Form 4 |
| SATO VICKI L Director | 2008-05-23 09:50:10 | 1,875 0 | 1,875 | Form 4 |
| Daniel D Ronald Director | 2007-06-06 11:51:41 | 1,875 0 | 1,875 | Form 4 |
| CROUCH TAYLOR President & COO | 2005-01-31 16:10:32 | 0 0 | 0 | Form 4 |
| PROSPECT VENTURE PARTNERS II LP PROSPECT VENTURE PARTNERS LP PROSPECT MANAGEMENT CO II LLC PROSPECT MANAGEMENT CO LLC 10% Owner | 2013-01-28 17:30:00 | 0 0 | 0 | Form 13G |
| Beacon Co 10% Owner | 2013-04-16 16:13:33 | 0 0 | 0 | Form 4 |
| Rosebay Medical Co L.P. 10% Owner | 2013-04-16 16:12:56 | 0 0 | 0 | Form 4 |